Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avantor, Inc. stock logo
AVTR
Avantor
$10.30
+2.1%
$8.70
$7.26
$15.93
$6.88B0.979.11 million shs10.62 million shs
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$300.15
+0.6%
$284.52
$236.73
$343.12
$8.05B1.08350,788 shs481,974 shs
Bruker Corporation stock logo
BRKR
Bruker
$60.91
+0.0%
$48.50
$28.53
$64.54
$9.27B1.312.79 million shs2.23 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avantor, Inc. stock logo
AVTR
Avantor
+2.19%+7.41%+22.63%+38.65%-24.36%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
+0.57%+6.13%-1.74%+13.19%+24.44%
Bruker Corporation stock logo
BRKR
Bruker
+0.03%+6.43%+25.28%+80.63%+48.82%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avantor, Inc. stock logo
AVTR
Avantor
$10.30
+2.1%
$8.70
$7.26
$15.93
$6.88B0.979.11 million shs10.62 million shs
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$300.15
+0.6%
$284.52
$236.73
$343.12
$8.05B1.08350,788 shs481,974 shs
Bruker Corporation stock logo
BRKR
Bruker
$60.91
+0.0%
$48.50
$28.53
$64.54
$9.27B1.312.79 million shs2.23 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avantor, Inc. stock logo
AVTR
Avantor
+2.19%+7.41%+22.63%+38.65%-24.36%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
+0.57%+6.13%-1.74%+13.19%+24.44%
Bruker Corporation stock logo
BRKR
Bruker
+0.03%+6.43%+25.28%+80.63%+48.82%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avantor, Inc. stock logo
AVTR
Avantor
1.94
Reduce$10.471.69% Upside
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.00
Hold$303.331.06% Upside
Bruker Corporation stock logo
BRKR
Bruker
2.40
Hold$53.00-12.99% Downside

Current Analyst Ratings Breakdown

Latest AVTR, BIO, and BRKR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/26/2026
Avantor, Inc. stock logo
AVTR
Avantor
Initiated CoverageMarket Perform$10.50
6/25/2026
Avantor, Inc. stock logo
AVTR
Avantor
UpgradeHold
6/24/2026
Bruker Corporation stock logo
BRKR
Bruker
Set Price Target$60.00
6/24/2026
Bruker Corporation stock logo
BRKR
Bruker
Boost Price TargetOverweight$53.00 ➝ $60.00
6/24/2026
Avantor, Inc. stock logo
AVTR
Avantor
Set Price Target$8.00
6/24/2026
Avantor, Inc. stock logo
AVTR
Avantor
Boost Price TargetUnderweight$7.00 ➝ $8.00
6/8/2026
Bruker Corporation stock logo
BRKR
Bruker
Boost Price TargetOverweight$55.00 ➝ $65.00
6/3/2026
Bruker Corporation stock logo
BRKR
Bruker
UpgradeSell (D)Sell (D+)
6/1/2026
Bruker Corporation stock logo
BRKR
Bruker
Initiated CoverageOutperformPeer Perform
6/1/2026
Avantor, Inc. stock logo
AVTR
Avantor
DowngradeUnderperform$7.00
6/1/2026
Avantor, Inc. stock logo
AVTR
Avantor
UpgradeStrong Sell
(Data available from 6/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avantor, Inc. stock logo
AVTR
Avantor
$6.55B1.07$1.55 per share6.66$8.16 per share1.26
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.59B3.10$10.09 per share29.76$276.16 per share1.09
Bruker Corporation stock logo
BRKR
Bruker
$3.44B2.70$3.38 per share18.04$16.28 per share3.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avantor, Inc. stock logo
AVTR
Avantor
-$530.20M-$0.81N/A12.265.85-8.42%9.95%4.78%8/7/2026 (Estimated)
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$759.90M$6.0749.4532.27N/A6.52%3.56%2.49%7/30/2026 (Estimated)
Bruker Corporation stock logo
BRKR
Bruker
-$8.60M-$0.24N/A24.961.95-0.65%11.60%4.25%8/4/2026 (Estimated)

Latest AVTR, BIO, and BRKR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2026Q1 2026
Bruker Corporation stock logo
BRKR
Bruker
$0.23$0.31+$0.08$0.02$795.62 million$823.40 million
4/30/2026Q1 2026
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$1.97$1.89-$0.08-$19.55$589.91 million$592.10 million
4/29/2026Q1 2026
Avantor, Inc. stock logo
AVTR
Avantor
$0.16$0.17+$0.01$0.06$1.54 billion$1.58 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Avantor, Inc. stock logo
AVTR
Avantor
N/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
Bruker Corporation stock logo
BRKR
Bruker
$0.200.33%+4.56%N/A N/A

Latest AVTR, BIO, and BRKR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/14/2026
Bruker Corporation stock logo
BRKR
Bruker
quarterly$0.050.35%6/22/20266/22/20267/7/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avantor, Inc. stock logo
AVTR
Avantor
0.68
1.76
1.17
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.12
3.21
2.37
Bruker Corporation stock logo
BRKR
Bruker
0.67
1.55
0.72

Institutional Ownership

CompanyInstitutional Ownership
Avantor, Inc. stock logo
AVTR
Avantor
95.08%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
Bruker Corporation stock logo
BRKR
Bruker
79.52%

Insider Ownership

CompanyInsider Ownership
Avantor, Inc. stock logo
AVTR
Avantor
0.28%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
30.34%
Bruker Corporation stock logo
BRKR
Bruker
27.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Avantor, Inc. stock logo
AVTR
Avantor
13,500682.76 million680.84 millionOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
7,45026.76 million18.64 millionOptionable
Bruker Corporation stock logo
BRKR
Bruker
11,085152.23 million110.82 millionOptionable

Recent News About These Companies

Is Bruker Corporation (BRKR) A Good Stock To Buy Now?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Avantor stock logo

Avantor NYSE:AVTR

$10.30 +0.22 (+2.13%)
Closing price 06/26/2026 03:59 PM Eastern
Extended Trading
$10.34 +0.04 (+0.44%)
As of 06/26/2026 07:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Bio-Rad Laboratories stock logo

Bio-Rad Laboratories NYSE:BIO

$300.15 +1.86 (+0.62%)
Closing price 06/26/2026 03:59 PM Eastern
Extended Trading
$300.75 +0.61 (+0.20%)
As of 06/26/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Bruker stock logo

Bruker NASDAQ:BRKR

$60.91 +0.02 (+0.03%)
Closing price 06/26/2026 04:00 PM Eastern
Extended Trading
$61.00 +0.09 (+0.15%)
As of 06/26/2026 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.